Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Shengxue Granules is a traditional Chinese medicine (TCM) herbal granule formulation combined with Western nutritional elements, primarily used for the treatment of iron deficiency anemia (IDA) in children and adults, as well as cancer-related anemia and renal anemia. Developed and manufactured by Jianmin Group, the formulation consists of 13 traditional Chinese medicinal herbs—including *Codonopsis pilosula*, *Poria cocos*, *Atractylodes macrocephala*, *Glycyrrhiza uralensis* (licorice), *Astragalus membranaceus*, *Dioscorea opposita* (Chinese yam), chicken gizzard membrane, tortoise shell, *Ophiopogon japonicus*, *Kadsura longepedunculata*, oysters, *Ziziphus jujuba* (jujube), and fossil bone (longgu)—co-formulated with ferrous sulfate and vitamin C. It works by strengthening the spleen and stomach to enhance gastrointestinal absorption while directly supplementing iron to promote erythropoiesis and improve hemoglobin levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jianpi shengxue granules.